COSMOS Pharmaceutical Corporation Technographics

Discover the latest software purchases and digital transformation initiatives being undertaken by COSMOS Pharmaceutical Corporation and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 5101 COSMOS Pharmaceutical Corporation employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.

During our research, we have identified that COSMOS Pharmaceutical Corporation has purchased the following applications: RELEX Automatic Replenishment and Allocation for Allocation and Replenishment in 2025, Amazon EC2 for Application Hosting and Computing Services in 2017, Lets Encrypt SSL for Secure Sockets Layer (SSL) in 2018 and the related IT decision-makers and key stakeholders.

Our database provides customer insight and contextual information on which enterprise applications and software systems COSMOS Pharmaceutical Corporation is running and its propensity to invest more and deepen its relationship with RELEX Solutions , Amazon Web Services (AWS) , Microsoft or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.

We have been analyzing COSMOS Pharmaceutical Corporation revenues, which have grown to $6.66 billion in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for COSMOS Pharmaceutical Corporation intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.